References
- NIDA. Cocaine. National Institute on drug abuse website; 2016 May 6 [cited 2018 Aug 28]. Available from: https://www.drugabuse.gov/publications/research-reports/cocaine
- Prosser JM, Hoffman RS. Cocaine, In: RS Hoffman, M Howland, NA Lewin, et al., editors. Goldfrank’s toxicologic emergencies, 10e. New York, NY: McGraw-Hill Education; 2015.
- Wood DM, Dargan PI, Hoffman RS. Management of cocaine-induced cardiac arrhythmias due to cardiac ion channel dysfunction. Clin Toxicol (Phila). 2009;47:14–23.
- Katz JL, Terry P, Witkin JM. Comparative behavioral pharmacology and toxicology of cocaine and its ethanol-derived metabolite, cocaine ethyl-ester (cocaethylene). Life Sci. 1992;50:1351–1361.
- Isner JM, Estes NA, Thompson PD, et al. Acute cardiac events temporally related to cocaine abuse. N Engl J Med. 1986;315:1438–1443.
- Schrem SS, Belsky P, Schwartzman D, et al. Cocaine-induced torsades de pointes in a patient with the idiopathic long QT syndrome. Am Heart J. 1990;120:980–984.
- Catravas JD, Waters IW. Acute cocaine intoxication in the conscious dog: studies on the mechanism of lethality. J Pharmacol Exp Ther. 1981;217:350–356.
- Guinn MM, Bedford JA, Wilson MC. Antagonism of intravenous cocaine lethality in nonhuman primates. Clin Toxicol. 1980;16:499–508.
- Sand IC, Brody SL, Wrenn KD, et al. Experience with esmolol for the treatment of cocaine-associated cardiovascular complications. Am J Emerg Med. 1991;9:161–163.
- National Center for Biotechnology Information. PubChem Compound Database; CID = 446220 [cited 2018 Nov 21]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/446220
- Arora NP, Berk WA, Aaron CK, et al. Usefulness of intravenous lipid emulsion for cardiac toxicity from cocaine overdose. Am J Cardiol. 2013;111:445–447.
- Chai PR, Hack JB. Intravenous lipid emulsion in the resuscitation of cocaine-induced cardiovascular arrest in a rat model. Am J Emerg Med. 2016;34:1452–1454.
- Hajjar K, Berbari I, El Tawil C, et al. Dual defibrillation in patients with refractory ventricular fibrillation. Am J Emerg Med. 2018;36:1474–1479.
- Richards JR, Garber D, Laurin EG, et al. Treatment of cocaine cardiovascular toxicity: a systematic review. Clin Toxicol (Phila). 2016;54:345–364.
- Grawe JJ, Hariman RJ, Winecoff AP, et al. Reversal of the electrocardiographic effects of cocaine by lidocaine. Part 2. Concentration-effect relationships. Pharmacotherapy. 1994;14:704–711.
- Hondeghem LM, Katzung BG. Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs. Annu Rev Pharmacol Toxicol. 1984;24:387–423.
- Shih RD, Hollander JE, Burstein JL, et al. Clinical safety of lidocaine in patients with cocaine-associated myocardial infarction. Ann Emerg Med. 1995;26:702–706.
- Al-Khatib SM, et al. 2017 AHA/ACC/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation. 2018;138:e272–e391.